| IL-6–based mortality risk model for hospitalized patients with COVID-19 R Laguna-Goya, A Utrero-Rico, P Talayero, M Lasa-Lazaro, ... Journal of Allergy and Clinical Immunology 146 (4), 799-807. e9, 2020 | 215 | 2020 |
| Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels TM Snyder, RM Gittelman, M Klinger, DH May, EJ Osborne, R Taniguchi, ... MedRxiv, 2020 | 204 | 2020 |
| GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ... Nature 617 (7962), 764-768, 2023 | 119 | 2023 |
| A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease JC Villaescusa, B Li, EM Toledo, PIA Rivetti di Val Cervo, S Yang, ... The EMBO journal 35 (18), 1963-1978, 2016 | 110 | 2016 |
| Molecular and functional definition of the developing human striatum M Onorati, V Castiglioni, D Biasci, E Cesana, R Menon, R Vuono, F Talpo, ... Nature neuroscience 17 (12), 1804-1815, 2014 | 89 | 2014 |
| WNT5A is transported via lipoprotein particles in the cerebrospinal fluid to regulate hindbrain morphogenesis K Kaiser, D Gyllborg, J Procházka, A Salašová, P Kompaníková, ... Nature communications 10 (1), 1498, 2019 | 81 | 2019 |
| Immunogenicity of anti-SARS-CoV-2 vaccines in common variable immunodeficiency D Arroyo-Sánchez, O Cabrera-Marante, R Laguna-Goya, ... Journal of Clinical Immunology 42 (2), 240-252, 2022 | 64 | 2022 |
| Longitudinal profile of circulating T follicular helper lymphocytes parallels anti-HLA sensitization in renal transplant recipients FL Cano-Romero, RL Goya, A Utrero-Rico, E Gómez-Massa, ... American Journal of Transplantation 19 (1), 89-97, 2019 | 56 | 2019 |
| Tocilizumab for the treatment of adult patients with severe COVID‐19 pneumonia: a single‐center cohort study M Fernández‐Ruiz, F López‐Medrano, MA Pérez‐Jacoiste Asín, ... Journal of medical virology 93 (2), 831-842, 2021 | 53 | 2021 |
| Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination P Almendro-Vázquez, R Laguna-Goya, M Ruiz-Ruigomez, A Utrero-Rico, ... PLoS pathogens 17 (12), e1010211, 2021 | 48 | 2021 |
| Alterations in circulating monocytes predict COVID-19 severity and include chromatin modifications still detectable six months after recovery A Utrero-Rico, C Gonzalez-Cuadrado, M Chivite-Lacaba, ... Biomedicines 9 (9), 1253, 2021 | 47 | 2021 |
| Innate lymphoid cells groups 1 and 3 in the epithelial compartment of functional human intestinal allografts P Talayero, E Mancebo, J Calvo-Pulido, S Rodríguez-Muñoz, I Bernardo, ... American Journal of Transplantation 16 (1), 72-82, 2016 | 45 | 2016 |
| A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID A Utrero-Rico, M Ruiz-Ruigómez, R Laguna-Goya, E Arrieta-Ortubay, ... Biomedicines 9 (11), 1540, 2021 | 40 | 2021 |
| Discordance between SARS-CoV-2–specific cell-mediated and antibody responses elicited by mRNA-1273 vaccine in kidney and liver transplant recipients M Fernández-Ruiz, P Almendro-Vázquez, O Carretero, T Ruiz-Merlo, ... Transplantation Direct 7 (12), e794, 2021 | 34 | 2021 |
| Defending against SARS-CoV-2: The T cell perspective P Almendro-Vázquez, R Laguna-Goya, E Paz-Artal Frontiers in Immunology 14, 1107803, 2023 | 33 | 2023 |
| Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses P Almendro-Vázquez, M Chivite-Lacaba, A Utrero-Rico, ... Frontiers in immunology 13, 981350, 2022 | 33 | 2022 |
| Early renal graft function deterioration in recipients with preformed anti-MICA antibodies: partial contribution of complement-dependent cytotoxicity E Sánchez-Zapardiel, MJ Castro-Panete, E Mancebo, P Morales, ... Nephrology Dialysis Transplantation 31 (1), 150-160, 2016 | 32 | 2016 |
| The future of cell therapies in the treatment of Parkinson's disease R Laguna Goya, WL Kuan, RA Barker Expert opinion on biological therapy 7 (10), 1487-1498, 2007 | 29 | 2007 |
| Interleukin-6-based mortality risk model for hospitalised COVID-19 patients LG Rocio, UR Alberto, T Paloma, LL Maria, RF Angel, N Laura, ... J Allergy Clin Immunol 146 (4), 799-807, 2020 | 22 | 2020 |
| IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts A Utrero-Rico, J Ruiz-Hornillos, C González-Cuadrado, CG Rita, ... Journal of Allergy and Clinical Immunology 147 (5), 1652-1661. e1, 2021 | 20 | 2021 |
